Clinical evaluation of Kuhuang Granules in the treatment of nonalcoholic steatohepatitis

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Participate and sign the informed consent form voluntarily;
•2. The age ranged from 18 to 60 years old;
•3. According to the diagnosis of nonalcoholic steatohepatitis, the liver fat content was more than 5%, ALT <= 5 x ULN and > 1 x ULN;
•4. Those who have not used other drugs for the treatment of nonalcoholic steatohepatitis within 3 months.

•1. Nash related cirrhosis;
•2. LDL > 4.14 mmol/L (indication for statins) or TG>5.6mmol/L (indication for fibrates);
•3. Those who are using heparin, thyroxine and other drugs that affect fat metabolism;
•4. Serious primary cardiovascular, liver, kidney, lung and hematological diseases, or serious diseases affecting survival, such as tumor or AIDS;
•5. Pregnant and lactating women;
•6. Those who have mental disorders can not give full informed consent;
•7. People with allergic constitution or known to be allergic to the components of the drug;
•8. Patients receiving other trial drugs within 3 months.

发起方

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine